Guidance by NIH, CDC and FDA to Coronavirus Pandemic in the United States of America

FDA's Coronavirus Response

National Cancer Institute (NIH), Center for Disease Control (CDC) and Food and Drug Administration (FDA) working with federal government and state partners are responding to the new pandemic of respiratory disease spreading from person-to-person caused by a novel (new) coronavirus. This disease is named “coronavirus disease 2019” (“COVID-19”).

Coronavirus can cause mild to severe illness; most severe illness occurs in older adults and adults with other underlying health issues.

Different parts of the United States are seeing different levels of coronavirus activity. The duration and severity of each pandemic phase can vary depending on the characteristics of the virus and the public health response.

Please refer to below official sources to track COVID-19 pandemic in the United States:

CDC is responding to the novel Coronavirus outbreak by CDC

COVID-19 is an emerging, rapidly evolving situation by NIH

FDA is working with U.S. Government partners, including CDC, and international partners to address the coronavirus disease 2019 (COVID-19) outbreak.

Latest Developments in Cancer

Leave a Comment

Your email address will not be published.

Previous reading
COVID-19: Tips, Statistics, and Everything You Need to Know
Next reading
Guidance to Sponsors on How to Manage Clinical Trials during the COVID-19 Pandemic by European Union